Treatment of diabetes with rosiglitazone and insulin
AssigneeSmithKline Beecham Corporation
InventorStephen Alistair Smith
Life of this patent
Estimating the term…
Abstract
A method for the treatment of diabetes mellitus and conditions associated with diabetes mellitus in a mammal, which method comprises administering an effective non-toxic and pharmaceutically acceptable amount of Compound (I) and insulin to a mammal in need thereof.
Claims15
A method for the treatment of diabetes mellitus and conditions associated with diabetes mellitus in a mammal, which method comprises administering an effective non-toxic and pharmaceutically acceptable amount of Compound (I) and insulin, to a mammal in need thereof.
A pharmaceutical composition comprising Compound (I), insulin and a pharmaceutically acceptable carrier therefor.
A pharmaceutical composition comprising Compound (I), insulin and a pharmaceutically acceptable carrier therefor, for use as an active therapeutic substance.
A pharmaceutical composition comprising Compound (I), insulin and a pharmaceutically acceptable carrier therefor, for use in the treatment of diabetes mellitus and conditions associated with diabetes mellitus.
Dependencies are inferred from the claim text.